We need your support if we are going to meet our $60,000 goal. Please help us out if you can. You can donate
via PayPal or major credit card, or if you prefer, you can send your donation by check or money order to:
Numbers On Napkins
Attn: Donations
PO Box 35254
Phoenix, AZ 85069
PLEASE MAKE PAYABLE TO: HAWK DISTRIBUTION
Craig was a wonderful father and husband. Over
years of friendship with both Chase and Moe, the
Cox family became almost a second family to them.
Craig was entertaining, funny, and just a pleasant
person to be around. He unfortunately was taken
from his family and friends because of a battle he
lost with ALS, more commonly known as Lou
Gerrhig's Disease. After his passing, his loved ones
started an organization in his name, dedicated to
help find a cure. Chase and Moe lost contact with
the Cox and Salomone families, and unfortunately
was not around when Craig passed. Both Moe and
Chase feel as though they owe it to Craig to make
this album, and donate a minimum of $20,000 in his
name. We ask that you help support with any
donation you can afford. If you do not wish to
donate to help get the album out, please donate to
the charity directly. There are those people in your
life that seem to have an effect on you. The giving
and caring people that would give you the shirt off
their back. The person that can somehow make
you laugh in the darkest of hours, and manage to
uplift your spirits. The people that worked hard to
provide for their family, and the person that is
someone you envy, and would like to be more like.
Craig was all of these. Numbers On Napkins sends
love to Craig, and his loving wife Rachael. And of
course his daughters, parents, siblings, and all of
his friends and family. He will be missed, but
forever in our hearts.
To learn more about the other charities we are supporting, just click on their name to get more information.
|
If you would like to make a donation to help support The J. Craig Cox Foundation, you can make a direct
donation at their website at: www.alsaz.org
Just what is ALS? Amyotrophic Lateral Sclerosis (ALS) is a motor neuron disease, first described in 1869 by
the noted French neurologist Jean-Martin Charcot. Although the cause of ALS is not completely understood,
the last decade has brought a wealth of new scientific understanding about the disease that provides hope for
the future.
Lou Gehrig first brought national and international attention to the disease in 1939 when he abruptly retired
from baseball after being diagnosed with ALS. Most commonly, the disease strikes people between the ages of
40 and 70, and as many as 30,000 Americans have the disease at any given time. ALS has cut short the lives of
other such notable and courageous individuals as Hall of Fame pitcher Jim "Catfish" Hunter, Senator Jacob
Javits, actors Michael Zaslow and David Niven, creator of Sesame Street Jon Stone, boxing champion Ezzard
Charles, NBA Hall of Fame basketball player George Yardley, pro football player Glenn Montgomery, golfer
Jeff Julian, golf caddie Bruce Edwards, musician Lead Belly (Huddie Ledbetter), photographer Eddie Adams,
entertainer Dennis Day, jazz musician Charles Mingus, composer Dimitri Shostakovich, former vice president
of the United States Henry A. Wallace and U.S. Army General Maxwell Taylor.
ALS is a neurodegenerative disease that usually attacks both upper and lower motor neurons and causes
degeneration throughout the brain and spinal cord. A common first symptom is a painless weakness in a hand,
foot, arm or leg, which occurs in more than half of all cases. Other early symptoms include speech swallowing
or walking difficulty.
The biological mechanisms that cause ALS are only partially understood. The only known cause of ALS is a
mutation of a specific gene: the SOD1 gene. This mutation is believed to make a defective protein that is toxic
to motor nerve cells. The SOD1 mutation, however, accounts for only 1 or 2 percent of ALS cases, or 20
percent of the familial (inherited) cases.
Familial ALS represents between five to 10 percent of all cases. The rest arise spontaneously and mysteriously,
making seemingly random attacks on previously healthy adults. ALS can strike anyone, anytime.
Physicians have limited choices for treating ALS, and the options that do exist have come into use within the
last 10 years. Studies suggest that patients' length of survival and quality of life are enhanced by night-time
breathing assistance early in the course of the disease and by aggressive application of alternate feeding
options to assure good nutrition once swallowing becomes difficult. At this time, Riluzole® is the only drug that
has been approved by the FDA for treatment of ALS. In clinical trials, Riluzole® has shown a slight benefit in
modestly increasing survival time.
Stem cell and gene therapy are promising areas of research. In a variety of studies, ALS mouse models are
being used to develop treatments that may someday lead to similar human clinical trials. Gene therapy is one
field of research where The ALS Association is concentrating support for more study.
More significant advances of research into ALS has occurred in the last decade than all of the time since
Charcot identified the disease. Advances in technology and the genetic revolution are aiding researchers in
unlocking the ALS mystery. As more scientists focus on this perplexing disease, the outlook for new
understanding brightens each day.
The J. Craig Cox Foundation is a charity we feel very proud to be a part of. We have shared the friendship of two
great friends throughout the past decade or so....Stephanie and Angelina Cox. Over the years, both Steph and
Angelina changed their last names through marriage, although the Cox name still holds strong because of their
charismatic father, J. Craig Cox.
The J. Craig Cox Foundation
|